Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/19/24 16:21 | 3/28/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | McBrinn Sylvia | CA | D | P | 9 | 2.35 | 0 | 4 | 26 | 19 | D | |||||||||||||||
12/26/23 19:43 | 12/26/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | McBrinn Sylvia | CA | D | P | 9 | 2.33 | 0 | 4 | 36 | 15 | D | |||||||||||||||
12/20/23 18:27 | 12/20/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P | 107 | 2.14 | 0 | 50 | 2 | 3,053 | D | ||||||||||||||
12/19/23 20:24 | 12/19/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | Steinman Lawrence | CA | D | P | 41 | 2.05 | 0 | 20 | 108 | 38 | D | |||||||||||||||
12/19/23 16:33 | 12/19/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | Vasquez Christian | CA | O | See Rema | P | 15 | 2.04 | 0 | 7 | 7 | 116 | D | ||||||||||||||
9/13/23 18:55 | 9/8/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | McBrinn Sylvia | CA | D | P | 5 | 2.54 | 0 | 2 | 22 | 11 | D | |||||||||||||||
3/30/23 19:17 | 3/29/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P | 101 | 2.47 | 0 | 41 | 1 | 3,026 | D | ||||||||||||||
3/29/23 17:20 | 3/28/23 | BCAB | Health | BioPrd | Biological Products, (No Diag | Vasquez Christian | CA | O | See Rema | P | 48 | 2.40 | 0 | 20 | 24 | 103 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |